Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MODAt: Atazanavir/ritonavir Monotherapy Maintenance in HIV
NCT01511809Phase 3Completed
- Sponsor
- IRCCS Ospedale San Raffaele
- Start
- Sep 2010
- Primary completion
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of atazanavir in human immunodeficiency virus type 1 infection (HIV-1), sponsored by IRCCS Ospedale San Raffaele. Started Sep 2010; status: completed.
02
Drugs
atazanavir
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT01511809.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01511809.